PREVOTELLA COPRI INCREASES FATTY LIVER DISEASE PROGRESSION IN HUMANS AND IN MOUSE

被引：0
|
作者：
Shera, Simer
Katzka, William
Pawar, Shrey
Orr, Max A.
Ha, John
Patel, Arpan A.
Benhammou, Jihane N.
Jacobs, Jonathan P.
Dong, Tien S.
机构：
来源：
GASTROENTEROLOGY | 2023年 / 164卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Sa1593
引用
收藏
页码：S1306 / S1306
页数：1
相关论文
共 50 条
  • [31] Non alcoholic fatty liver disease and eNOS dysfunction in humans
    Persico, Marcello
    Masarone, Mario
    Damato, Antonio
    Ambrosio, Mariateresa
    Federico, Alessandro
    Rosato, Valerio
    Bucci, Tommaso
    Carrizzo, Albino
    Vecchione, Carmine
    BMC GASTROENTEROLOGY, 2017, 17
  • [32] Protein glutathionylation increases in liver of patients with nonalcoholic fatty liver disease (nafld)
    Nobili, V.
    Devito, R.
    Comparcola, D.
    Sartorelli, M. R.
    Guidi, R.
    Manco, M.
    Alisi, A.
    Tozzi, G.
    Passarelli, C.
    Gaeta, L.
    Fruhwirth, R.
    Piemonte, F.
    Marcellini, M.
    DIGESTIVE AND LIVER DISEASE, 2007, 39 (10) : A85 - A85
  • [33] Nonalcoholic Fatty Liver Disease Increases the Risk of Anxiety and Depression
    Labenz, Christian
    Huber, Yvonne
    Michel, Maurice
    Nagel, Michael
    Galle, Peter R.
    Kostev, Karel
    Schattenberg, Joern M.
    HEPATOLOGY COMMUNICATIONS, 2020, 4 (09) : 1293 - 1301
  • [34] Tamoxifen increases risk of fatty liver disease in overweight women
    Reactions Weekly, 2005, 1042 (1) : 5 - 5
  • [35] Diet-induced mouse model of fatty liver disease and nonalcoholic steatohepatitis reflecting clinical disease progression and methods of assessment
    Clapper, Jason R.
    Hendricks, Michelle D.
    Gu, Guibao
    Wittmer, Carrie
    Dolman, Carrie S.
    Herich, John
    Athanacio, Jennifer
    Villescaz, Christiane
    Ghosh, Soumitra S.
    Heilig, Joseph S.
    Lowe, Carolyn
    Roth, Jonathan D.
    AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2013, 305 (07): : G483 - G495
  • [36] SHG/TPEF MICROSCOPY IMAGING IN THE FIBROSIS AND STEATOSIS PROGRESSION OF NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) IN MOUSE MODELS
    Wang, Xiaoxiao
    Jin, Rui
    Li, Xiaohe
    Yang, Qiang
    Teng, Xiao
    Wu, Nan
    Rao, Huiying
    Liu, Feng
    HEPATOLOGY, 2021, 74 : 985A - 985A
  • [37] PROGRESSION OF ETHANOL-INDUCED FATTY LIVER WITH TIME IN ALCOHOLIC LIVER DISEASE
    Fernando, H.
    Kondraganti, S.
    Bhopale, K. K.
    Kaphalia, B. S.
    Ansari, G. A. S.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2010, 34 (08) : 121A - 121A
  • [38] Spotlight on liver macrophages for halting injury and progression in nonalcoholic fatty liver disease
    Laursen, Tea Lund
    Mellemkjaer, Anders
    Moller, Holger Jon
    Gronbaek, Henning
    Kazankov, Konstantin
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2022, 26 (08) : 697 - 705
  • [39] THE EFFECTS OF MODERATE DRINKING ON LIVER FIBROSIS PROGRESSION IN SUBJECTS WITH FATTY LIVER DISEASE
    Kinoshita, Kaori
    Toshikuni, Nobuyuki
    Tsuchishima, Mutsumi
    Tsutsumi, Mikihiro
    GASTROENTEROLOGY, 2017, 152 (05) : S1113 - S1113
  • [40] Targeting mitochondria to oppose the progression of nonalcoholic fatty liver disease
    Grattagliano, Ignazio
    Montezinho, Liliana P.
    Oliveira, Paulo J.
    Fruhbeck, Gema
    Gomez-Ambrosi, Javier
    Montecucco, Fabrizio
    Carbone, Federico
    Wieckowski, Mariusz R.
    Wang, David Q. -H.
    Portincasa, Piero
    BIOCHEMICAL PHARMACOLOGY, 2019, 160 : 34 - 45
12345